Can CTCA prevent cardiac event after MI ruled out?
-
By
-
Andrea Surnit
-
November 12, 2026
-
4 min
By
Andrea Surnit
November 12, 2026
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026
In a 12,327-patient trial, asundexian cut recurrent ischemic stroke risk by 26% alongside antiplatelets.
by Mouj Hijazi
November 10, 2026